Cantor Fitzgerald analysts maintained their Overweight rating and $19.00 price target for Avita Medical Ltd . (NASDAQ:RCEL) stock, despite the shares being down nearly 50% over the past year.

A former S&P executive shares his views of U.S. creditworthiness under President Trump.

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

The report, entitled Unlocking Operational Excellence in Fund Administration through AI, is based on insights from in-depth ...

Shares of FactSet Research Systems Inc. FDS rose 1.14% to $459.39 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6, ...

ViaSat (VSAT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices - ...

Shares of CVS Health Corp. were having their best day in 26 years on Wednesday, after the drugstore chain and healthcare-services company beat quarterly profit expectations by a wide margin, and as ...

WEC Energy boosts its dividend for the 22nd year, with strong growth prospects and a $28B investment plan. Find out why WEC ...

On Wednesday the Labor Department is expected to report that in January the consumer price index rose 2.9% from a year ago, according to economists surveyed by FactSet. If accurate, it would be ...

Wells Fargo lowered the firm’s price target on FactSet (FDS) to $500 from $503 and keeps an Equal Weight rating on the shares. The acquisition ...